A disrupted microbiota in IBD is associated with elevated proinflammatory cytokines (including TNF-α and IL-6) and the activation of inflammatory signaling pathways like nuclear factor kappa B (NF-κB), contributing to sustained gastrointestinal inflammation [114]. This evidence concerns the gene TNF and inflammatory bowel disease.